SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from MAXTOR CORP (CIK 0000711039) — Oct 6, 2005

MAXTOR CORP (CIK 0000711039)
Date: Oct. 6, 2005 · CIK: 0000711039 · Accession: 0000950134-05-018892

AI Filing Summary & Sentiment

File numbers found in text: 001-16447

Referenced dates: August 1, 2005, July 11, 2005, September 19, 2005

Date
October 6, 2005
Author
Branch Chief — Legal
Form
CORRESP
Company
MAXTOR CORP (CIK 0000711039)

Letter

Division of Corporation Finance Maxtor Corporation Registration Statement on Form S-3 filed July 7, 2005 Form 10-Q for the period ended July 2, 2005 File No. 001-16447

Dear Mr. Shuman:

We are writing on behalf of our client, Maxtor Corporation (the “Company”), in response to the comment letter from the Staff of the Securities and Exchange Commission (the “SEC”) dated September 19, 2005 with respect to the Company’s Form S-3 and Form 10-Q as identified above. The italicized paragraphs below restate the numbered paragraphs in the Staff’s comment letter and the discussion set out below each such paragraph is the Company’s response to the Staff’s comments.

Attached hereto is a marked version of the Company’s registered rescission offer on Form S-3/A submitted to the Staff supplementally for their review and consideration. Subject to Staff approval, the Company will file an amended Form S-3 on EDGAR prior to submitting its acceleration request in accordance with Rule 461.

Form S-3, Our Rescission Offer, page 17

1.

We note your response to comment no. 2 in our letter dated August 1, 2005. Please provide a materially complete description of the offering and the circumstances leading to your conclusion that your sale of securities under your 1998 employee stock purchase plan may not have been exempt from registration or qualification under the Securities Act resulting in your possible noncompliance with federal securities law.

In response to the Staff’s comment, the following clarifying description was added to page 17: “In June 2005 we determined that ESPP share reserve increases of 2,100,000 and 9,000,000 shares approved by stockholders at the 2000 and 2002 Annual Meetings, respectively, had not been registered on a Form S-8 registration statement prior to the offer and sale of the shares to

Mr. Mark P. Shuman

October 6, 2005

Page Two

plan participants.” The Company respectfully submits that this revised disclosure under “Our Rescission Offer — Background” provides investors with a materially complete description of the offering and the circumstances leading to the Company’s conclusion that the above described offer and sale of securities under the 1998 ESPP may not have been exempt from registration or qualification under the Securities Act resulting in possible noncompliance with the federal securities law.

Form 10-Q for the period ended July 2, 2005, Controls and Procedures, page 43

2.

We note your response to comment no. 1 in our letter dated July 11, 2005 and your disclosure in your Form 10-Q filed August 4, 2005. Notwithstanding the parenthetical after your initial use of the term “complex, non-routine transactions” in your disclosure on page 43 of your Form 10-Q and your response that you had identified the transactions which required adjustments, your use of such term remains insufficient to inform investors as to the full nature of complex, non-routine transactions that may pose challenges to you. Your parenthetical and prior disclosure discloses some transactions which required adjustments, but the term is ambiguous as to what other transactions coming within the term “complex, non-routine transactions” may have caused or will cause problems for you if your identified weaknesses are not resolved. Please revise your disclosure to provide greater detail and specificity as to the types of transactions encompassed by the term “complex, non-routine transactions.”

In the judgment of management and based upon a review of the transactions reasonably likely to occur in the Company’s business, the Company advises that the transactions listed in the parenthetical after the initial use of the term “complex, non-routine transactions” in the Company’s most recent Form 10-Q is a complete listing of transactions that may cause challenges for the Company if the identified material weakness is not remediated. The Staff will note that the Company did not qualify or limit the parenthetical definition of “complex, non-routine transactions.” The Company continues to believe that the parenthetical definition of complex, non-routine transactions provided to investors with the second quarter 2005 Form 10-Q is a complete listing of such transactions. Accordingly, the Company respectfully submits that the disclosure provided to investors is an accurate, complete and unambiguous listing of complex, non-routine transactions that the Company reasonably expects may cause challenges if the material weakness is not remediated.

* * *

Mr. Mark P. Shuman

October 6, 2005

Page Three

Should you have any questions regarding the foregoing or require any additional information, please do not hesitate to contact the undersigned at (650) 833-2026 or John Saia at (650) 833-2444. Thank you very much for your assistance.

Very truly yours,
DLA Piper Rudnick Gray Cary US LLP

Show Raw Text
CORRESP
1
filename1.htm

corresp

[DLA PIPER RUDNICK GRAY CARY US LLP
LETTERHEAD]

    October 6, 2005

    OUR FILE NO. 344258-916200

Mr. Mark P. Shuman

Branch Chief — Legal

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE — Room 4561

Washington, D.C. 20549

    Re:

    Maxtor Corporation

    Registration Statement on Form S-3 filed July 7, 2005

    Form 10-Q for the period ended July 2, 2005

    File No. 001-16447

Dear Mr. Shuman:

We are writing on behalf of our client, Maxtor Corporation (the “Company”), in response to the
comment letter from the Staff of the Securities and Exchange Commission (the “SEC”) dated September
19, 2005 with respect to the Company’s Form S-3 and Form 10-Q as identified above. The italicized
paragraphs below restate the numbered paragraphs in the Staff’s comment letter and the discussion
set out below each such paragraph is the Company’s response to the Staff’s comments.

Attached hereto is a marked version of the Company’s registered rescission offer on Form S-3/A submitted to the Staff supplementally for their review and consideration.
Subject to Staff approval, the Company will file an amended Form S-3 on EDGAR prior to submitting its
acceleration request in accordance with Rule 461.

Form S-3, Our Rescission Offer, page 17

    1.

    We note your response to comment no. 2 in our letter dated August 1, 2005. Please provide a
materially complete description of the offering and the circumstances leading to your
conclusion that your sale of securities under your 1998 employee stock purchase plan may not
have been exempt from registration or qualification under the Securities Act resulting in your
possible noncompliance with federal securities law.

In response to the Staff’s comment, the following clarifying description was added to page 17: “In
June 2005 we determined that ESPP share reserve increases of 2,100,000 and 9,000,000 shares
approved by stockholders at the 2000 and 2002 Annual Meetings, respectively, had not been
registered on a Form S-8 registration statement prior to the offer and sale of the shares to

Mr. Mark
P. Shuman

October 6, 2005

Page Two

plan participants.” The Company respectfully submits that this revised disclosure under “Our
Rescission Offer — Background” provides investors with a materially complete description of the
offering and the circumstances leading to the Company’s conclusion that the above described offer
and sale of securities under the 1998 ESPP may not have been exempt from registration or
qualification under the Securities Act resulting in possible noncompliance with the federal
securities law.

Form 10-Q for the period ended July 2, 2005, Controls and Procedures, page 43

    2.

    We note your response to comment no. 1 in our letter dated July 11, 2005 and your disclosure
in your Form 10-Q filed August 4, 2005. Notwithstanding the parenthetical after your initial
use of the term “complex, non-routine transactions” in your disclosure on page 43 of your Form
10-Q and your response that you had identified the transactions which required adjustments,
your use of such term remains insufficient to inform investors as to the full nature of
complex, non-routine transactions that may pose challenges to you. Your parenthetical and
prior disclosure discloses some transactions which required adjustments, but the term is
ambiguous as to what other transactions coming within the term “complex, non-routine
transactions” may have caused or will cause problems for you if your identified weaknesses are
not resolved. Please revise your disclosure to provide greater detail and specificity as to
the types of transactions encompassed by the term “complex, non-routine transactions.”

In the judgment of management and based upon a review of the transactions reasonably likely to
occur in the Company’s business, the Company advises that the transactions listed in the
parenthetical after the initial use of the term “complex, non-routine transactions” in the
Company’s most recent Form 10-Q is a complete listing of transactions that may cause challenges for
the Company if the identified material weakness is not remediated. The Staff will note that the
Company did not qualify or limit the parenthetical definition of “complex, non-routine
transactions.” The Company continues to believe that the parenthetical definition of complex,
non-routine transactions provided to investors with the second quarter 2005 Form 10-Q is a complete
listing of such transactions. Accordingly, the Company respectfully submits that the disclosure
provided to investors is an accurate, complete and unambiguous listing of complex, non-routine
transactions that the Company reasonably expects may cause challenges if the material weakness is
not remediated.

* * *

Mr. Mark P. Shuman

October 6, 2005

Page Three

Should you have any questions regarding the foregoing or require any additional information, please
do not hesitate to contact the undersigned at (650) 833-2026 or John Saia at (650) 833-2444. Thank
you very much for your assistance.

Very truly yours,

DLA Piper Rudnick Gray Cary US LLP

/s/ Diane Holt Frankle

Diane Holt Frankle

diane.frankle@dlapiper.com

    cc:

    Mr. Daniel Lee, Securities and Exchange Commission

    Dr. C.S. Park, Chairman and Chief Executive Officer, Maxtor Corporation

    Mr. Duston Williams, Exec. Vice President, Finance & Chief Financial Officer, Maxtor Corporation